[ 4 ] Ravizza T, Gagliardi B, Noé F, et al. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy[J]. Neurobiol Dis, 2008, 29(1): 142-160.
[2]
[ 1 ] Baxendale S, O’Toole A. Epilepsy myths: alive and foaming in the 21st century[J]. Epilepsy Behav, 2007, 11(2): 192-196.
[3]
[ 2 ] Walker AE. Allergic phenomenon as basic mechanisms in epilepsy[M]//Jaspar HH, Ward AA Jr, Pope A. Basic mechanisms of the epilepsies. London: Churchill, 1969: 812-814.
[4]
[ 3 ] Vezzani A, Janigro D. Leukocyte-endothelial adhesion mechanisms in epilepsy: cheers and jeers[J]. Epilepsy Curr, 2009, 9(4): 118-121.
[5]
[ 5 ] Vezzani A, Balosso S, Ravizza T. The role of cytokines in the pathophysiology of epilepsy[J]. Brain Behav Immun, 2008, 22(6): 797-803.
[ 7 ] Sinha S, Patil S, Jayalekshmy V, et al. Do cytokines have any role in epilepsy[J]. Epilepsy Res, 2008, 82(2-3): 171-176.
[8]
[ 8 ] Ravizza T, Boer K, Redeker S, et al. The IL-1beta system in epilepsy-associated malformations of cortical development[J]. Neurobiol Dis, 2006, 24(1): 128-143.
[9]
[ 9 ] Pernot F, Heinrich C, Barbier L, et al. Inflammatory changes during epileptogenesis and spontaneous seizures in a mouse model of mesiotemporal lobe epilepsy[J]. Epilepsia, 2011, 52(12): 2315-2325.
[10]
Alapirtti T, Rinta S, Hulkkonen J, et al. Interleukin-6, interleukin-1 receptor antagonist and interleukin-1beta production in patients with focal epilepsy: a video-EEG study[J]. J Neurol Sci, 2009, 280(1-2): 94-97.
[11]
Lehtim？ki KA, Ker？nen T, Palmio J, et al. Increased plasma levels of cytokines after seizures in localization-related epilepsy[J]. Acta Neurol Scand, 2007, 116(4): 226-230.
[12]
Hulkkonen J, Koskikallio E, Rainesalo S, et al. The balance of inhibitory and excitatory cytokines is differently regulated in vivo and in vitro among therapy resistant epilepsy patients[J]. Epilepsy Res, 2004, 59(2-3): 199-205.
[13]
Peltola J, Palmio J, Korhonen L, et al. Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures[J]. Epilepsy Res, 2000, 41(3): 205-211.
[14]
Bauer S, Cepok S, Todorova-Rudolph A, et al. Etiology and site of temporal lobe epilepsy influence postictal cytokine release[J]. Epilepsy Res, 2009, 86(1): 82-88.
Choi J, Koh S. Role of brain inflammation in epileptogenesis[J]. Yonsei Med J, 2008, 49(1): 1-18.
[17]
Peltola J, Hurme M, Miettinen A, et al. Elevated levels of interleukin-6 May occur in cerebrospinal fluid from patients with recent epileptic seizures[J]. Epilepsy Res, 1998, 31(2): 129-133.
[18]
Fukuda M, Suzuki Y, Ishizaki Y, et al. Interleukin-1beta enhances susceptibility to hyperthermia-induced seizures in developing rats[J]. Seizure, 2009, 18(3): 211-214.
[19]
Haspolat S, Baysal Y, Duman O, et al. Interleukin-1alpha, interleukin-1beta, and interleukin-1Ra polymorphisms in febrile seizures[J]. J Child Neurol, 2005, 20(7): 565-568.
[20]
Tomoum HY, Badawy NM, Mostafa AA, et al. Plasma interleukin-1beta levels in children with febrile seizures[J]. J Child Neurol, 2007, 22(6): 689-692.
[21]
Jauneau AC, Ischenko A, Chatagner A, et al. Interleukin-1beta and anaphylatoxins exert a synergistic effect on NGF expression by astrocytes[J]. J Neuroinflammation, 2006, 3: 8.
[22]
Bartfai T, Sanchez-Alavez M, Andell-Jonsson S, et al. Interleukin-1 system in CNS stress: seizures, fever, and neurotrauma[J]. Ann N Y Acad Sci, 2007, 1113: 173-177.
[23]
Rijkers K, Majoie HJ, Hoogland G, et al. The role of interleukin-1 in seizures and epilepsy: a critical review[J]. Exp Neurol, 2009, 216(2): 258-271.
[24]
Steinman L. Elaborate interactions between the immune and nervous systems[J]. Nat Immunol, 2004, 5(6): 575-581.
[25]
Vezzani A, Ravizza T, Balosso S, et al. Glia as a source of cytokines: implications for neuronal excitability and survival[J]. Epilepsia, 2008, 49(Suppl 2): 24-32.
